Latest News
Our Capacity Strengthening Hub launches on The Global Health Network today!
The MRC CTU Capacity Strengthening Hub has launched today on The Global Health Network digital platform.
Scotland approves the use of abiraterone in patients with high-risk non-metastatic prostate cancer
NHS Scotland have approved the use of the drug abiraterone to treat patients with prostate cancer at high risk of spreading to other parts of the body.
New podcast episode: Sharing results of clinical trials with participants (part 2)
New podcast episode: Sharing results of clinical trials with participants (part 2)
STREAM stage 2 study finds all-oral and six-month treatment regimens to be safe and effective
STREAM stage 2 study finds all-oral and six-month treatment regimens to be safe and effective
Practical guidance for running late-phase platform trials
Practical guidance for running late-phase platform trials